|
TMEM170B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.81970011176236E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.25530030814502E-10 |
| Normal-vs-Stage2 |
1.809010E-04 |
| Normal-vs-Stage3 |
1.14380000004743E-06 |
| Normal-vs-Stage4 |
3.223200E-03 |
| Stage1-vs-Stage2 |
2.310800E-01 |
| Stage1-vs-Stage3 |
9.000000E-01 |
| Stage1-vs-Stage4 |
5.452400E-01 |
| Stage2-vs-Stage3 |
3.261400E-01 |
| Stage2-vs-Stage4 |
8.121400E-01 |
| Stage3-vs-Stage4 |
6.374800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.78409525936263E-11 |
| Normal-vs-AfricanAmerican |
8.97800000010385E-07 |
| Normal-vs-Asian |
7.217000E-04 |
| Caucasian-vs-AfricanAmerican |
8.139800E-01 |
| Caucasian-vs-Asian |
3.929400E-01 |
| AfricanAmerican-vs-Asian |
4.356200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62792002100787E-12 |
| Normal-vs-Female |
4.033400E-04 |
| Male-vs-Female |
5.556400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.649969999995E-05 |
| Normal-vs-Extreme_Weight |
1.67565961106675E-12 |
| Normal-vs-Obese |
7.35860000045108E-07 |
| Normal-vs-Extreme_Obese |
5.85589999824165E-08 |
| Normal_Weight-vs-Extreme_Weight |
1.689390E-01 |
| Normal_Weight-vs-Obese |
6.609400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.995800E-01 |
| Extreme_Weight-vs-Obese |
1.685540E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.413000E-01 |
| Obese-vs-Extreme_Obese |
1.220640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.412400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.58050000034871E-07 |
| Normal-vs-Age(61-80Yrs) |
1.94511073914327E-12 |
| Normal-vs-Age(81-100Yrs) |
4.22629999999868E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.963800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.963020E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.384800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.689800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.850600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.421800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.06930000304462E-08 |
| Normal-VS-Type2 PRCC |
7.08970000040665E-07 |
| Normal-VS-KIRP CIMP |
1.204220E-03 |
| Normal-VS-Unclassified PRCC |
2.300300E-03 |
| Type1 PRCC-VS-Type2 PRCC |
9.994800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.231400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.375800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.511800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.199640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.758200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.96519997444733E-09 |
| Normal-vs-N1 |
1.457500E-03 |
| Normal-vs-N2 |
7.16010029044867E-10 |
| N0-vs-N1 |
1.142030E-01 |
| N0-vs-N2 |
3.203800E-03 |
| N1-vs-N2 |
1.215930E-03 |
|
|
